Keystone Bio

Keystone Bio is a clinical-stage biopharmaceutical company with novel disease-modifying, precision antibacterial biotherapeutics targeting significant, largely unaddressed bacterial drivers of systemic inflammation, which greatly contribute to multiple inflammatory diseases such as heart disease and dementia/Alzheimer's. It also provides companion diagnostics to diagnose/identify high-risk populations and monitor treatment.